Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.99 Analyst target: $7.00 Upside: 609.87%
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.